Influence of a 12-week supplementation with collagen peptides and resistance training on the intracellular signalling pathway of muscular protein biosynthesis as well as ultrastructural and functional adaptations in skeletal muscles
- Conditions
- Effects of resistance training and collagen peptide intake on muscular adaptations in healthy volunteers
- Registration Number
- DRKS00027112
- Lead Sponsor
- Institut für Sport und Sportwissenschaft, Albert-Ludwigs-Universität Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 30
Male gender
- age between 18-29
- BMI 18.5 - 25
- Physically active:
- < 150 minutes/week of moderate-intensity exercise (e.g. 5 x 30 minutes/week) or < 75 minutes/higher-intensity exercise (running, cycling, playing sports).
- No regular participation in strength training during the last 12 months
- Stable weight and nutritional behaviour (mixed diet)
- Informed consent
- No contraindications to exercise according to ACSM guidelines
- Metabolically healthy
- Regular participation in strength and endurance training during the last 12 months.
- Malignant diseases in the past 5 years.
- Cardiac disease (e.g. chronic heart disease, arrhythmia, valvular disease, arthritis etc.). Cardiac disease (e.g. chronic heart disease, arrhythmia, heart valve disease, arthritis, etc.).
- Arterial hypertension (RRsyst > 200 mmHg and/or RRdiast > 105 mmHg) at rest.
- Presence of insulin-dependent diabetes mellitus (IDDM).
- Presence of a lipometabolic disorder.
- Regular intake of medication.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in mTOR activation / phosphprylation
- Secondary Outcome Measures
Name Time Method All secondary outcomes will be investigated either in the acute study (single strength training session with supplementation) or in the long-term study (12-week):<br><br>Acute study:<br>- Genome sequencing/transcriptome sequencing-.<br>- Protein activation (AKT, AMPK, FoXo, MuRF-1, MAFbx, PRAS40, ERK1/2, LCB3, LBC I/II, Antrogin-1).<br><br>Long-term study:<br>- Histological examinations (muscle fibre distribution, muscle cell nucleus density, fibroblast density, satellite cell distribution)<br>- Protein concentrations (AKT, AMPK, FoXo, MuRF-1, MAFbx, PRAS40, ERK1/2, LCB3, LBC I/II, Antrogin-1)<br>- Muscle volume (MRI)<br>- Tendon volume (MRT)<br>- Muscle strength